NMTC - Neuroone Medical Technologies Corp

Momentum: Bearish

Recent News

NMTC Stock Gains as FDA Clears OneRF System for Facial Pain Treatment

Zacks Commentary • 3 weeks, 6 days ago • score: -0.04

NeuroOne stock rallies after FDA clears its OneRF system, a minimally invasive solution targeting severe facial pain, scheduled to launch in late 2025.

Neutral

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update

GlobeNewswire • 1 month, 2 weeks ago • score: -0.13

EDEN PRAIRIE, Minn., July 31, 2025 ( GLOBE NEWSWIRE ) -- NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC ) ( "NeuroOne" or the "Company" ) , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will ...

Neutral

NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time

GlobeNewswire • 1 month, 2 weeks ago • score: -0.13

Neutral

NeuroOne to Attend MedInvest's MedTech, AI & Digital Health Conference on June 3-4, 2025

GlobeNewswire • 3 months, 2 weeks ago • score: -0.13

EDEN PRAIRIE, Minn., May 29, 2025 ( GLOBE NEWSWIRE ) -- NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC ) ( "NeuroOne" or the "Company" ) , a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

NeuroOne Medical Technologies Corporation is a medical technology company. The company is headquartered in Eden Prairie, Minnesota.

52W High

$1.39

52W Low

$0.40

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.72

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-2.10

EV/Revenue (<3 favorable)

4.81

P/S (TTM) (<3 favorable)

5.98

P/B (<3 favorable)

4.85

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

11.72%

Institutions (25–75% balanced)

33.63%

Shares Outstanding

49,999,500

Float

43,602,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

6,629,100

Gross Profit (TTM)

-1,225,151

EPS (TTM)

-0.16

Profit Margin (>10% good)

-0.81%

Operating Margin (TTM) (higher better)

-1.11%

ROE (TTM) (>15% strong)

-0.95%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

1.05

Momentum

Bearish momentum

Value

0.0316

0.0272

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025